What is Insmed's operating cash flow?

Insmed (INSM) reported operating cash flow of -$222.74M in Q1 2026.

How has Insmed's operating cash flow changed year-over-year?

Insmed's operating cash flow increased by 15.0% year-over-year, from -$262.09M to -$222.74M.

What is the long-term trend for Insmed's operating cash flow?

Over 4 years (2021 to 2025), Insmed's operating cash flow has grown at a 26.7% compound annual growth rate (CAGR), from -$363.3M to -$935.01M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Insmed INSM Operating Cash Flow

Operating Cash Flow at other companies

Sarepta Therapeutics, Inc.SRPT

-$202.68M+65.3%

United TherapeuticsUTHR

$463.3M+0.5%

Solid Biosciences Inc.SLDB

-$47.23M-48.3%

ANI PharmaceuticalsANIP

$58.38M+66.8%

Regeneron PharmaceuticalsREGN

$1.08B+3.2%

SavaraSVRA

-$33.05M-21.5%

Other financials

Income statement

See full

Revenue$306.0M+230%

Gross profit$258.5M+261%

Operating income-$153.3M+38.2%

Net income-$163.6M+36.3%

EPS (diluted)-$0.76+46.5%

Balance sheet

See full

Cash & equivalents$582.2M+44.4%

Total debt$580.3M-49.2%

Total equity$704.9M+611%

Total assets$2.1B+15.2%

Cash flow

See full

CapEx$3.5M-65.4%

Free cash flow-$226.2M+16.9%

Valuation

See full

Market cap$23.11B+25.2%

Enterprise value$23.11B+29.9%

P/S28.2×-18.2×

Profitability

See full

Gross margin81.8%+5.3pp

Operating margin-140.6%-43.9pp

Net margin-144.4%-45.3pp

FCF margin-112.5%-35.3pp

Returns & leverage

See full

Return on equity-294.5%—

Debt / equity0.8×-10.7×

Current ratio4.5×-1.4×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insmed's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Insmed's operating cash flow?: Insmed (INSM) reported operating cash flow of -$222.74M in Q1 2026.
How has Insmed's operating cash flow changed year-over-year?: Insmed's operating cash flow increased by 15.0% year-over-year, from -$262.09M to -$222.74M.
What is the long-term trend for Insmed's operating cash flow?: Over 4 years (2021 to 2025), Insmed's operating cash flow has grown at a 26.7% compound annual growth rate (CAGR), from -$363.3M to -$935.01M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.